Home > Income Statement > CORONA REMEDIES

CORONA REMEDIES
Profit Before Tax

    Back to Income Statement
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Profit Before Tax History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Profit Before Tax ₹199 Cr₹1,185 Cr₹111 Cr₹111 Cr

What is the latest Profit Before Tax of CORONA REMEDIES ?

The latest Profit Before Tax ratio of CORONA REMEDIES is ₹199 Cr based on Mar2026 Consolidated results.
Year Profit Before Tax
Mar2026₹199 Cr
Mar2025₹1,185 Cr
Mar2024₹111 Cr
Mar2023₹111 Cr

How is Profit Before Tax of CORONA REMEDIES Trending?

Years Profit Before Tax % Change
Mar2026 ₹199 Cr
-83.24
Mar2025 ₹1,185 Cr
968.48
Mar2024 ₹111 Cr
0.00
Mar2023 ₹111 Cr -

Compare Profit Before Tax of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,310.7 Cr -0.7% -6.8% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,684.0 Cr 0.1% -5% 5.4% Stock Analytics
DIVIS LABORATORIES ₹241,311.0 Cr -1.7% 0.2% 39.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,079.0 Cr -2.5% -5.5% 30.2% Stock Analytics
CIPLA ₹107,528.0 Cr 0.9% -2.6% -14.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,667.0 Cr 0.1% 7.6% -3.5% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

-0.7%

-6.8%

NA
SENSEX

2.7%

-0.7%

-10.5%


You may also like the below Video Courses